You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

BIO Submits Comments Re: CMS HCPCS Public Meeting

<div>
RE: Centers for Medicare and Medicaid Services Healthcare Common Procedure Coding System Public Meeting, May 7, 2015</div>
<div>
&nbsp;</div>
<div>
Dear Ms. Carver:</div>
<div>
&nbsp;</div>
<div>
The Biotechnology Industry Organization (BIO) is pleased to provide comments in response to the May 7 Centers for Medicare and Medicaid Services (CMS) Healthcare Common Procedure Coding System (HCPCS) Public Meeting Agenda for Drugs, Biologicals and Radiopharmaceuticals (&ldquo;Public Meeting Agenda&rdquo;).</div>

Jennifer Carver
HCPCS Public Meeting Coordinator
Centers for Medicare & Medicaid Services
7500 Security Boulevard, Mail Stop C5–08–27
Baltimore, MD 21244–1850
 
BY ELECTRONIC DELIVERY
 
RE: Centers for Medicare and Medicaid Services Healthcare Common Procedure Coding System Public Meeting, May 7, 2015
 
Dear Ms. Carver:
 
The Biotechnology Industry Organization (BIO) is pleased to provide comments in response to the May 7 Centers for Medicare and Medicaid Services (CMS) Healthcare Common Procedure Coding System (HCPCS) Public Meeting Agenda for Drugs, Biologicals and Radiopharmaceuticals (“Public Meeting Agenda”).
 
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO’s members develop medical products and technologies to treat patients afflicted with serious diseases, to delay the onset of these diseases, or to prevent them in the first place. In that way, our members’ novel therapeutics, vaccines, and diagnostics not only have improved health outcomes, but also have reduced healthcare expenditures due to fewer physician office visits, hospitalizations, and surgical interventions. 

See the full comment letter here.